IMMUNE RESPONSE TO LEISHMANIA MAJOR
IMMUNE RESPONSE TO LEISHMANIA MAJOR
批准号:
6373201
负责人:
RICHARD GRAEME TITUS
金额:
$30.91万
依托单位国家:
美国
项目类别:
财政年份:
1993
资助国家:
美国
项目状态:
已结题
起止时间:
1993-04-01 至 2003-06-30
关键词:
B lymphocyte CD40 molecule Leishmania major MHC class I antigen T lymphocyte antigen presenting cell cellular immunity cellular pathology colony stimulating factor genetically modified animals host organism interaction immunoregulation in situ hybridization interleukin 6 intracellular parasitism laboratory mouse leishmaniasis leukocyte activation /transformation molecular pathology monokines polymerase chain reaction prostaglandin E protozoal antigen receptor expression tissue /cell culture
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (Adapted from the Applicant's Abstract): Following infection
with Leishmania major (Lm), there is outgrowth of Th1 cells in mice that
resolve the infection, but outgrowth of Th2 cell in mice that succumb to
disease. This project will test 3 major subhypotheses: 1) To test the
hypothesis that differential expression of MHC (I-A/E) and/or accessory
(ICAM), LFA/co-stimulatory molecules (B7, CD40) by APCs and the secretion of
monokines/factors by A{Cs influences Lm specific Th priming syngereic
system; 2) to examine congenic/chimeric combinations of APCs and responding
T cells to further test the hypothesis that APCs influence Th priming and to
test additional hypothesis; 3) to monitor the expression of APC molecules
important to T cell priming in cutaneous lesions of Lm and in the lymph
nodes draining the lesion, and to test the hypothesis that factors that
influence or are secreted by APCs (e.g., monokines, prostaglandin E2 (PGE2)
affect Lm specific Th priming and the outcome of infection with Lm.
期刊论文(16)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Leishmania major-specific, CD4+, major histocompatibility complex class II-restricted T cells derived in vitro from lymphoid tissues of naive mice.
利什曼原虫主要特异性,CD4+,主要的组织相容性复合物II类限制的T细胞在体外衍生自天真小鼠的淋巴组织。
DOI:
10.1084/jem.178.1.101
发表时间:
1993-07-01
期刊:
JOURNAL OF EXPERIMENTAL MEDICINE
影响因子:
15.3
作者:
[Shankar, A H, Titus, R G]
通讯作者:
Titus, R G
Rapid early onset lymphocyte cell death in mice resistant, but not susceptible to Leishmania major infection.
早发性淋巴细胞快速死亡的小鼠具有抵抗力,但不易受重大利什曼原虫感染。
DOI:
10.1023/a:1009601200580
发表时间:
2000
期刊:
Apoptosis : an international journal on programmed cell death
影响因子:
--
作者:
[Desbarats,J, Stone,JE, Lin,L, Zakeri,ZF, Davis,GS, Pfeiffer,LM, Titus,RG, Newell,MK]
通讯作者:
Newell,MK
Leishmania major-parasitized macrophages augment Th2-type T cell activation.
主要利什曼原虫寄生的巨噬细胞增强 Th2 型 T 细胞的激活。
DOI:
--
发表时间:
1994
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
[Chakkalath,HR, Titus,RG]
通讯作者:
Titus,RG
Leishmania major: differential resistance to infection in C57BL/6 (high interferon-alpha/beta) and congenic B6.C-H-28c (low interferon-alpha/beta) mice.
重大利什曼原虫:C57BL/6(高干扰素-α/β)和同类 B6.C-H-28c(低干扰素-α/β)小鼠对感染的抵抗力存在差异。
DOI:
10.1006/expr.1996.0099
发表时间:
1996
期刊:
Experimental parasitology.
影响因子:
--
作者:
[Shankar,AH, Morin,P, Titus,RG]
通讯作者:
Titus,RG
Resolution of an infection with Leishmania braziliensis confers complete protection to a subsequent challenge with Leishmania major in BALB/c mice.
巴西利什曼原虫感染的解决可以为 BALB/c 小鼠随后应对重大利什曼原虫的攻击提供完全的保护。
DOI:
10.1590/s0074-02761999000100015
发表时间:
1999
期刊:
Memorias do Instituto Oswaldo Cruz
影响因子:
2.8
作者:
[Lima,HC, DeKrey,GK, Titus,RG]
通讯作者:
Titus,RG
共 6 条
Biology of Vector/Aerosol Transmission of Bunyaviridae
-
批准号:7641029
-
项目类别:
-
资助金额:$29.39万
-
财政年份:2008
-
负责人:RICHARD GRAEME TITUS
-
依托单位:
Arthropod vector-based vaccines for leishmaniasis
-
批准号:7578892
-
项目类别:
-
资助金额:$43.93万
-
财政年份:2005
-
负责人:RICHARD GRAEME TITUS
-
依托单位:
Anthropod vector-based vaccines for leishmaniasis
-
批准号:7072356
-
项目类别:
-
资助金额:$43.02万
-
财政年份:2005
-
负责人:RICHARD GRAEME TITUS
-
依托单位:
Biology of Vector/Aerosol Transmission of Bunyaviridae
-
批准号:7126670
-
项目类别:
-
资助金额:$24.45万
-
财政年份:2005
-
负责人:RICHARD GRAEME TITUS
-
依托单位:
Arthropod vector-based vaccines for leishmaniasis
-
批准号:7373564
-
项目类别:
-
资助金额:$43.0万
-
财政年份:2005
-
负责人:RICHARD GRAEME TITUS
-
依托单位:
Arthropod vector-based vaccines for leishmaniasis
-
批准号:7178441
-
项目类别:
-
资助金额:$42.94万
-
财政年份:2005
-
负责人:RICHARD GRAEME TITUS
-
依托单位:
Arthropod vector-based vaccines for leishmaniasis
-
批准号:6958136
-
项目类别:
-
资助金额:$35.43万
-
财政年份:2005
-
负责人:RICHARD GRAEME TITUS
-
依托单位:
IMMUNE RESPONSE TO LEISHMANIA MAJOR
-
批准号:2687936
-
项目类别:
-
资助金额:$28.22万
-
财政年份:1993
-
负责人:RICHARD GRAEME TITUS
-
依托单位:
IMMUNE RESPONSE TO LEISHMANIA MAJOR
-
批准号:2065334
-
项目类别:
-
资助金额:$3.54万
-
财政年份:1993
-
负责人:RICHARD GRAEME TITUS
-
依托单位:
IMMUNE RESPONSE TO LEISHMANIA MAJOR
-
批准号:2065335
-
项目类别:
-
资助金额:$15.09万
-
财政年份:1993
-
负责人:RICHARD GRAEME TITUS
-
依托单位:
IMMUNE RESPONSE TO LEISHMANIA MAJOR
-
批准号:6169619
-
项目类别:
-
资助金额:$29.97万
-
财政年份:1993
-
负责人:RICHARD GRAEME TITUS
-
依托单位:
IMMUNE RESPONSE TO LEISHMANIA MAJOR
-
批准号:2886656
-
项目类别:
-
资助金额:$29.2万
-
财政年份:1993
-
负责人:RICHARD GRAEME TITUS
-
依托单位:
IMMUNE RESPONSE TO LEISHMANIA MAJOR
-
批准号:3144981
-
项目类别:
-
资助金额:$23.34万
-
财政年份:1993
-
负责人:RICHARD GRAEME TITUS
-
依托单位:
IMMUNE RESPONSE TO LEISHMANIA MAJOR
-
批准号:2065336
-
项目类别:
-
资助金额:$23.7万
-
财政年份:1993
-
负责人:RICHARD GRAEME TITUS
-
依托单位:
IMMUNE RESPONSE TO LEISHMANIA MAJOR
-
批准号:2065337
-
项目类别:
-
资助金额:$25.65万
-
财政年份:1993
-
负责人:RICHARD GRAEME TITUS
-
依托单位:
SAND FLY AND TICK SALIVA AND DISEASE
-
批准号:2063878
-
项目类别:
-
资助金额:$22.26万
-
财政年份:1989
-
负责人:RICHARD GRAEME TITUS
-
依托单位:
SAND FLY AND TICK SALIVA AND DISEASE
-
批准号:2330342
-
项目类别:
-
资助金额:$25.21万
-
财政年份:1989
-
负责人:RICHARD GRAEME TITUS
-
依托单位:
ROLE OF SANDFLY SALIVA IN LEISHMANIASIS
-
批准号:3141768
-
项目类别:
-
资助金额:$13.72万
-
财政年份:1989
-
负责人:RICHARD GRAEME TITUS
-
依托单位:
SAND FLY AND TICK SALIVA AND DISEASE
-
批准号:6349788
-
项目类别:
-
资助金额:$30.38万
-
财政年份:1989
-
负责人:RICHARD GRAEME TITUS
-
依托单位:
SAND FLY AND TICK SALIVA AND DISEASE
-
批准号:2063880
-
项目类别:
-
资助金额:$24.19万
-
财政年份:1989
-
负责人:RICHARD GRAEME TITUS
-
依托单位: